Benzinga's Top Ratings Upgrades, Downgrades For November 2, 2022 By: Benzinga via Benzinga November 02, 2022 at 10:06 AM EDT Upgrades According to Evercore ISI Group, the prior rating for BioCryst Pharmaceuticals Inc (NASDAQ:BCRX) was changed from In-Line ... Read More >> Related Stocks: Abiomed Inc Aeva Technologies Inc Aeye Inc Arcturus Therapeutics Holdings Inc Avista Corp Bally's Corp Biocryst Pharma Inc Blueprint Medicines Corp Canopy Growth Corp Catalent Inc Centerspace Check Point Software Cleveland-Cliffs Inc Cloudflare Inc Cl A Cronos Group Inc Crowdstrike Holdings Inc Datadog Inc Cl A Denali Therapeutics Inc Dynatrace Inc Ecolab Frequency Therapeutics Inc Hubspot Inc Innoviz Technologies Ltd Ipg Photonics Corp KKR & Company LP Legend Biotech Corp ADR Lineage Cell Therapeutics Inc Luminar Technologies Inc Microsoft Nasdaq OMX Group Okta Inc Cl A Onespaworld Holdings Ltd Ouster Inc Palo Alto Networks Inc Premier Inc Cl A Rb Global Inc Resideo Technologies Inc Seaspine Holdings Semler Scientific Snowflake Inc Cl A Sorrento Therapeutics Inc Tilray Brands Inc Tpg Re Finance Trust Inc Twilio Universal Logis Holdings Workday Inc Zscaler Inc